Photo by sandym10 from unsplash
Preferentially expressed antigen in melanoma (PRAME) is a tumor‐associated antigen that is frequently expressed in cutaneous melanoma and can be evaluated by immunohistochemistry. Earlier studies on PRAME utilized case‐control study… Click to show full abstract
Preferentially expressed antigen in melanoma (PRAME) is a tumor‐associated antigen that is frequently expressed in cutaneous melanoma and can be evaluated by immunohistochemistry. Earlier studies on PRAME utilized case‐control study designs that may misestimate diagnostic accuracy and lack generalizability.
Keywords:
prame;
immunohistochemistry;
melanoma;
diagnostic accuracy;
study
Journal Title: Journal of Cutaneous Pathology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cutaneous Pathology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!